MRK vs AMGN
By Alex · Tickerpine
Merck & Co., Inc. vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | AMGN |
|---|---|---|
| Price | $145.27 | $439.26 |
| Market cap | $358.41B | $237.48B |
| P/E ratio | 117.2 | 27.3 |
| ROE | 6.96% | 91.47% |
| Profit margin | 4.77% | 22.95% |
| Revenue growth | 5.10% | 9.50% |
| Dividend yield | 2.34% | 2.29% |
| Beta | 0.22 | 0.41 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs AMGN in plain English
- MRK is the bigger company — about 1.5× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.3 vs 117.2).
- AMGN earns a higher return on equity (91% vs 7%).
- AMGN is growing revenue faster (10% vs 5%).
- MRK has the higher dividend yield (2.34% vs 2.29%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.